PFIZER SUED OVER SIDE EFFECTS OF ANTI-IMFLAMMATORY DRUG
Nov 17, 2004 | Dow Jones
A lawsuit has been filed in State Supreme Court in Manhattan accusing Pfizer, Inc., of failing to adequately and timely warn consumers about the life-threatening side effects associated with its anti-inflammatory drug, Bextra. The suit was filed on behalf of the estate of a 46- year old New Jersey resident; the law firms Parker & Waichman and Seeger Weiss said yesterday. Bextra was approved in 2001 for treatment of osteoarthritis, adult rheumatoid arthritis and dysmenorrhea. In October, Pfizer said Bextra was associated with an increase in heart attacks and strokes in two studies of patients taking the drug after heart bypass surgery. A representative of Pfizer, based in New York, was not immediately available for comment.
Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us. Prior results do not guarantee or predict a similar outcome with respect to any future matter. | Attorney Advertising.